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The adult, virgin mammary gland is a highly or-
ganized tree-like structure formed by ductswith
hollowed lumen. Although lumen formation
during pubertal development appears to involve
apoptosis, the molecular mechanisms that
regulate this process are not known. Here, we
demonstrate that disruption of the BH3-only
proapoptotic factor Bim in mice prevents in-
duction of apoptosis in and clearing of the lu-
men in terminal end buds during puberty. How-
ever, cells that fill the presumptive luminal
space are eventually cleared from the adjacent
ducts by a caspase-independent death pro-
cess. Within the filled Bim/ ducts, epithelial
cells are deprived of matrix attachment and un-
dergo squamous differentiation prior to clear-
ing. Similarly, we also detect squamous differ-
entiation in vitro when immortalized mammary
epithelial cells are detached from the matrix.
These data provide important mechanistic in-
formation on the processes involved in sculpt-
ing the mammary gland and demonstrate that
BIM is a critical regulator of apoptosis in vivo.
INTRODUCTION
During embryogenesis and puberty, the mammary gland
undergoes amorphogenetic program that leads to the de-
velopment of a hollow ductal system terminating in alveo-
lae. Mammary development during puberty is an excellent
model by which to study the process of lumen formation
in vivo. From 4 to 8 weeks after birth, the rudimentary
mammary tree undergoes extensive expansion that re-
sults from proliferation and invasion at the leading front
of the ductal outgrowths. The highly proliferative bulbous
structures at the tips of these expanding outgrowths, re-
ferred to as terminal end buds (TEBs), develop in response
to elevated levels of reproductive hormones. A luminal
space forms behind TEBs during ductal expansion, andDevelopmethis process is hypothesized to require clearance of an in-
ner cell population by apoptosis (Humphreys et al., 1996).
The TEB is composed of two main cell populations,
distinguishable by their morphology and expression of
specific markers: the cap cells and the body cells (Daniel
et al., 1995). The cap cells are located in the outer layer
that is in contact with the stroma and are considered to
be progenitors of the myoepithelial cells. The body cells,
organized with 6–10 cell layers within TEBs, are thought
to be precursors for the luminal lineage. A rare scattered
third population is occasionally observed in the TEB
body, which expresses cap/myoepithelial cell markers
and is hypothesized to comprise cap cells left behind
during the extensive TEB outgrowth (Williams and Daniel,
1983).
It was previously shown that apoptosis is detected in
nonproliferating body cells of TEBs (Humphreys et al.,
1996). The spatial and temporal pattern of apoptosis sug-
gested that caspase-mediated apoptosis maintains the
lumen within the expanding duct. In addition, mosaic
overexpression of Bcl-2 was found to partially suppress
body cell apoptosis and to disrupt TEB structure. How-
ever, lumen formation was not inhibited, and mature, vir-
gin mammary glands developed normally in this trans-
genic model (Humphreys et al., 1996). Thus, the mosaic
overexpression of Bcl-2 precluded evaluation of the con-
sequences of inhibition of apoptosis in this model. While
apoptosis is detected in TEBs of the developing glands,
the mechanisms underlying lumen formation and the me-
diators of this process are not known. Elucidation of this
apoptotic program is critical not only for understanding
mammary gland development, but also tumorigenesis,
as repopulation of the luminal space with cancer cells is
a hallmark of early breast tumors.
One potential mechanism for the regulation of luminal
apoptosis has been proposed from studies utilizing a
three-dimensional (3D) in vitro model of mammary acini.
Human MCF-10A mammary epithelial cells (MECs) grown
in 3D cultures form acini-like structures with a hollow lu-
men that clears by an apoptotic program. Because the
inner acinar cells that lack attachment to the extracellular
matrix (ECM) undergo apoptosis, it has been proposed
that matrix deprivation, at least in part, contributes to the
induction of apoptosis by a process analogous to anoikis.ntal Cell 12, 221–234, February 2007 ª2007 Elsevier Inc. 221
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detachment (Frisch and Francis, 1994). In the 3D model,
caspase activation is regulated by induction of the pro-
apoptotic factor BIM (Reginato et al., 2005). BIM is a
BH3-only member of the proapoptotic Bcl-2 intracellular
protein family, which also includes Bmf, Bik, Bad, Bid,
Puma, Noxa, and Hrk (Huang and Strasser, 2000). During
apoptosis, these proteins activate cytochrome c release
and subsequent caspase activation by binding and inhib-
iting antiapoptotic Bcl-2 familymember proteins or by trig-
gering Bax oligomerization (Huang and Strasser, 2000). In
the MCF-10A 3D model, BIM expression correlates tem-
porally with lumen formation, and inhibition ofBIM expres-
sion by small interfering RNA (siRNA) significantly delays
apoptotic cell death of the central cell cluster (Reginato
et al., 2005). Inhibition of BIM expression by siRNA also
decreased apoptosis ofMCF-10A cells during anoikis (Re-
ginato et al., 2003). These data demonstrate that lumen
formation in mammary acini and apoptosis during anoikis
are dependent on the induction of BIM. However, whether
BIM is a regulator of caspase activation and lumen forma-
tion in the mammary gland in vivo is not known. Further-
more, other mechanisms of anoikis in mouse MEC lines
have been reported that apparently do not involve regula-
tion by BIM (Wang et al., 2004). It is not known which of
these in vitro models might be most representative of
luminal death in the mammary gland in vivo.
To investigate the molecular mechanisms underlying
apoptosis in mammary gland morphogenesis, we have
examined the role of BIM-mediated cell death by utilizing
Bim/mice (Bouillet et al., 2001). Our results indicate that
Bim is expressed constitutively in the mammary epithe-
lium from the earliest stage of embryonic development.
MECs lacking Bim were deficient for apoptosis induction
in TEBs and ducts at 5 weeks, and this was associated
with an absence of lumen formation. Surprisingly, ducts
in the Bim/ mouse showed signs of caspase-indepen-
dent death and squamous differentiation, and by 8 weeks
the luminal spaces in these ducts had hollowed. These
data demonstrate that BIM is required for caspase-
dependent cell death in the mammary gland, and that in
the absence of primary death mechanisms, such as apo-
ptosis, alternative clearance mechanisms contribute to
proper lumen formation in the mammary gland in vivo.
RESULTS
Bim Is Widely Expressed during Mammary
Gland Development in the Mouse
Bim expression was analyzed during mouse mammary
development by X-Gal whole-mount staining of heterozy-
gousBim+/LacZ embryos (Bouillet et al., 2001).Bim expres-
sion was detected in mammary buds that arise from the
epidermal embryo flank at embryonic day 12.5 (E12.5)
(Figure 1A). Thereafter, Bim expression was maintained
in mammary epithelium throughout embryonic mammary
gland development (Figures 1A–1C). Bim was also de-
tected in the epithelial placode of primordial hair follicles
at E14.5 (b-galactosidase activity), which, like the mam-222 Developmental Cell 12, 221–234, February 2007 ª2007 Elsemary buds, are appendages, derived from the ectoderm
(Figure 1B). At E18.5, Bim expression was detected in
the mammary gland as well as in the fat pad precursor
(Figure 1C). After this period, Bim expression became
restricted to the mammary epithelium (ducts and TEBs)
during pubertal development (Figures 1D and 1E). Paraffin
sections of the X-Gal-stainedmammary glands at 5 weeks
showed that Bim is expressed in both mammary luminal
andmyoepithelial cells (data not shown). A previous report
had shown that Bim mRNA was detected in the mature
gland by in situ hybridization (O’Reilly et al., 2000). Here,
we show that BIM is also expressed at the protein level
in mammary TEBs (Figures 1F and 1G) and ducts (Fig-
ure 1H). In a control, we detected no BIM expression in
Bim/mammary tissue sectionswhen the same antibody
was used (data not shown).
Loss of Bim Triggers a Transient Luminal Filling
in TEBs and Terminal Ducts during Puberty
To investigate whether BIM plays a role in postnatal mam-
mary morphogenesis, whole-mount-stained mammary
glands dissected fromBim/ femalemicewere examined
(Bouillet et al., 2001). No significant differences between
wild-type and Bim/ mammary glands were detected in
glands fromneonatal (1weekof age) or juvenile (3–4weeks
of age) periods of growth (see Figure S1 in the Supplemen-
tal Data available with this article online). In addition, the
overall pattern of ductal branching and expansion in the
fat pad was indistinguishable in glands from wild-type
andBim/mice throughout postnatal development (com-
pare left panels of Figures 2A, 2D, and 2F to those of Fig-
ures 2B, 2E, and 2G; Figure S1). However, close examina-
tion of TEBsat 5weeks indicated thatwhilewild-type TEBs
contained a well-defined lumen (Figure 2A), the structures
fromBim/mice were filled (Figure 2B). Quantification in-
dicated that 86.6%± 9.3%ofBim/ TEBs, versus 4.4%±
1.3% (p < 1E04) of wild-type TEBs, lacked a detectable
lumen at 5 weeks (Figure 2C). Analysis of the distribution
of terminal end size revealed that 12.4% ± 3% of the
Bim/distal structureswere greater than 50,000 mm2 (ter-
minal ends are designated as TEBs from the 30,000 mm2
size range), compared to 5.5% ± 2.3% (p < 0.01) in the
wild-type (Figure 2C). Thus, a significant percentage of
the filled Bim/ TEBs displayed an increase in size. By
6 weeks, the distal ducts in the Bim/ mammary gland
that were filled at 5 weeks began to show marked hollow-
ing; indicating that the ductal-filling phenotype induced by
loss of Bim was transient (Figure 2E). Finally, the Bim/
ductswere completely hollowed at 8weeks, and thewhole
mammary glands were indistinguishable from the wild-
type glands (compare Figure 2F to Figure 2G).
Histological analysis of hematoxylin and eosin-stained
serial sections from wild-type and Bim/ mammary
glands at 5–8 weeks (Figure 3 and data not shown) con-
firmed the results of whole-mount analysis described
above (Figure 2). Although TEBs in wild-type mice at 5
weeks contained clearly discernable cap and body cells
(Figure 3A), and the luminal and myoepithelial cell bilayer
was organized in the ducts (Figure 3C), the luminal spacevier Inc.
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BIM-Mediated Apoptosis in Mammary Terminal End BudFigure 1. Bim Expression in the Developing Mouse Mammary Gland
(A) X-Gal-stained E12.5 heterozygous Bim+/LacZ embryo. The inset shows a high-magnification view of the second and third pair of mammary buds.
The scale bar is 1100 mm in the main panel and 200 mm in the inset.
(B) X-Gal-stained E15.5 Bim+/ female embryo. Bim is expressed in the mammary and hair follicle buds. The inset shows a high-magnification view of
a mammary bud (fourth pair). The scale bar is 700 mm in the main panel and 200 mm in the inset.
(C) X-Gal-stained E18.5 Bim+/ female skin explant showing Bim expression in the mammary gland. The scale bar is 100 mm.
(D) X-Gal staining of a Bim+/ mammary gland at 5 weeks. The scale bar is 150 mm.
(E) High-magnification view of the TEB and distal duct shown in (D). The scale bar is 15 mm.
(F–H) BIM immunostaining (Epitomics antibody #1036-1) of a (F–G) TEB and (H) proximal duct at 5 weeks.
(G) High-magnification view of the TEB shown in (F). The scale bar is 25 mm in (F), 12 mm in (G), and 20 mm in (H).
fl, forelimb; hl, hindlimb; B#, mammary bud; lymph, lymph node; TEB, terminal end bud; pr, proximal.in Bim/ TEBs (Figure 3B) and distal ducts (Figures 3D–
3F) was almost completely filled with epithelial cells. This
inner cell population was composed of an unorganized
epithelial mass (Figures 3B and 3E) and scattered struc-
tures that resemble squamous cell clusters (see Figures
3B and 3F). These data demonstrate that the loss of Bim
perturbs the morphogenesis of TEBs and distal ducts
andmay lead to squamous transdifferentiation of a subset
of the epithelial inner cell population. At 6 weeks, a similar
mixture of epithelial and squamous cells was still detect-
able in the remaining filled ducts (Figure 3H). In addition,Developmisolated squamous clusters embedded in a basophilic
secretion (stained by eosin) were also observed in the hol-
lowed proximal ducts of the Bim/ mammary glands
(Figure 3I). Histological analysis of 8-week-old Bim/
mammary glands (Figures 3K and 3L) revealed differences
with the wild-type glands (Figure 3J) that were not detect-
able in the whole-mount staining (Figures 2F and 2G). At 8
weeks, Bim/ ducts were completely hollowed, but they
contained some acidophilic debris (stained by hematoxy-
lin) encased in a basophilic secretion (Figures 3K and 3L),
as well as ghost cells (cells with a pale-pink nucleus andental Cell 12, 221–234, February 2007 ª2007 Elsevier Inc. 223
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BIM-Mediated Apoptosis in Mammary Terminal End BudFigure 2. Comparison of Whole-Mount Bim/ and Control Mammary Glands during Puberty
(A and B) Whole-mount staining of mammary glands from 5-week-old (A) Bim+/+ and (B) Bim/ mice at low (left panel) and high (right panel) mag-
nification. The luminal space is filled (white arrow) in Bim/ TEBs ([B], right panel). The scale bars are 300 mm in the main panels and 60 mm in the
insets.
(C) Morphometric study Bim/ TEBs at 5 weeks. Left panel: percentage (mean ± SD) of TEBs without any detectable luminal space inBim+/+ (4.4% ±
1.3%, n = 7) andBim/ (86.6% ± 9.3%, n = 8) mammary glands at 5 weeks. Right panel: size distribution (mm2) of terminal ends of the ducts inBim+/+
(n = 4) and Bim/ (n = 4) mammary glands at 5 weeks. The size distribution of terminal ends in the Bim+/+ and Bim/ glands is (mean ± SD): 66.7% ±
7.8% (+/+) and 56.6%± 6.3% (/) for sizes below 20,000 mm2, 15.2% ± 1.7% (+/+) and 16.9% ± 2.6% (/) between 20,000 and 30,000 mm2, 8% ±
3.7% (+/+) and 7.6% ± 2.3% (/) from 30,000 to 40,000 mm2, 4.6% ± 1.1% (+/+) and 6.5% ± 1% (+/+) between 40,000 and 50,000 mm2 (paired t test
with p < 0.05), and 5.5% ± 2.3% (+/+) and 12.4% ± 3% (/) for TEBs above 50,000 mm2 (paired t test with p < 0.01).
(D and E) Whole-mount staining of mammary glands from 6- to 7-week-old (D) wild-type and (E) Bim/mice at low and high magnification. Note that
the luminal space is clearing (black arrow) in (E). The scale bars are 300 mm in the main panels, 30 mm in the right insets, and 60 mm in the left insets.
(F and G)Whole-mount staining of 8-week-old (F) wild-type control and (G)Bim/mammary glands at low and highmagnification. The scale bars are
550 mm in the main panels and 60 mm in the insets.
TEB, terminal end bud; ln, lymph node.transparent cytoplasm) (Figure 3L) in the proximal and dis-
tal ducts. The wild-type mammary ducts contained a
basophilic secretionwith no evidence of acidophilic debris
(Figure 3J). Interestingly, neither inflammation nor stromal
activation was detectable by histology in theBim/mam-
mary gland at any of the stages examined in this study
(data not shown). Thus, these data indicate that the failure
to clear a lumen in Bim/ mammary glands is transient,
and they also suggest that a death process independent
of Bim can clear the mammary ducts.224 Developmental Cell 12, 221–234, February 2007 ª2007 ElseThe Transient Luminal Filling Observed in the Bim/
Mammary Gland Correlates with Decreased
Apoptosis in the Terminal End Bud during Puberty
Based on the proapoptotic function of Bim, we hypothe-
sized that the lack of lumen formation observed in Bim/
TEBs and ducts at 5 weeks could be a consequence of
decreased apoptosis of body cells. Using the TUNEL
method to detect apoptotic cells, we found that the per-
centage of TUNEL-positive cells in Bim/ TEBs (1.1% ±
0.45%) is dramatically reduced compared to wild-typevier Inc.
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BIM-Mediated Apoptosis in Mammary Terminal End BudTEBs (10.6%± 1.7%, p < 1E04) (Figures 4A, 4B, and 4E).
Similarly, an antibody recognizing activated caspase 3
confirmed that apoptotic activity was decreased in
Bim/ TEBs (1.86% ± 0.38%) compared to their wild-
type counterparts (10.7% ± 1.75%, p < 1E04) (Figures
4C–4E). Although the proapoptotic function of BIM and
other BH3-only proteins is well documented, and it is
therefore likely that the Bim/-filling phenotype is largely
explained by the loss of apoptosis in TEBs and ducts, we
investigated whether enhanced proliferation and/or al-
tered cell differentiation could also contribute to the lumi-
nal filling. Quantification of BrdU incorporation revealed a
slight decrease in the percent of proliferating TEB cells in
Bim/ TEBs compared to wild-type TEBs (Figures 4F–
4H) that is most likely due to the increased number of
TEB body cells. The proliferation rate of the cap cells in
Bim/ TEBs (42.8% ± 6.6%) was comparable to that of
control TEBs (42.4% ± 5.4%), while supernumerary cells
in the center part of the filledBim/ TEBs did not incorpo-
rate BrdU (Figure 4G). To assess whether the loss of Bim
affects the differentiation of TEB cells, we immunostained
glands from 5-week-old mice with antibodies that recog-
nize either the transcription factor p63 (basal cell marker)
or MUC1 (luminal cell marker). Cap cells and scattered
basal cells specifically expressed p63, while the luminal
body cells were positive for MUC1 (Figure 4I). According
to the analyzed markers (Figures 4I and 4J), loss of Bim
does not appear to prevent cells from differentiating into
expected cell subpopulations. Moreover, the expression
patterns of luminal pubertal markers such as estrogen
receptor a and progesterone receptor were not altered
in theBim/mammary epithelial bilayer (data not shown).
Taken together, these data confirmed the conclusion that
the inhibition of lumen development in Bim/ TEBs was
due to a defect in apoptotic cell death.
The Mammary Cells in the Clearing Luminal
Space of the Bim/ Mammary Glands Undergo
Caspase-Independent Cell Death at 6–7 Weeks
A careful analysis of the architecture of the Bim/ glands
revealed that ductal cells with epithelial morphology were
separated from the outer luminal epithelial cells and orga-
nized into large, isolated ductal islets (Figures 4K–4O). The
segregation of these islets could result from loss of adhe-
sion to the outer luminal epithelial cells since E-cadherin
is lost from the apical membrane of luminal cells after
polarization. The integrity of cells in these clusters was
also lost over time (see the loss of b-catenin staining in Fig-
ures 4K–4O), and TUNEL staining revealed detection of
fragmented DNA (Figures 4K and 4L). Interestingly, there
was very little evidence of apoptosis in these cell clusters
based on the near absence of staining with antibody to ac-
tivated caspase 3 (Figures 4M–4O), cellular blebbing, or
condensed nuclei (Figures 4K–4O). The activation of cas-
pase 3 (the terminal caspase in the pathway) was moni-
tored as readout for activation of the caspase cascade
since it is downstream of both intrinsic and extrinsic apo-
ptotic pathways. However, in addition, we found that cas-
pase 8 was not activated in the Bim/ ducts at 5 orDevelopm6 weeks based on immunohistochemistal analysis (data
not shown), and neither activated caspase 8 (Figure S2)
nor truncated BID (tBID), a reporter of caspase 8 activity
(data not shown), were detected by immunoblotting at
the same stages. These results suggested that the cen-
trally localized cells die by a caspase-independent cell
death (CICD) mechanism. The squamous clusters in the
filled ducts also displayed a similar CICD process at 6–7
weeks (Figures 4P and 4Q). Quantitatively, we observed
a 14.1-fold increase in the number of TUNEL-positive cells
(10.6% ± 0.8%) compared to apoptotic cells with active
caspase 3 (0.75% ± 0.15%, p < 1E04) in the filled duct
at 6 weeks (see Figure 4R). As a control, equivalent
amounts of caspase 3 activity and DNA fragmentation
(TUNEL) were detected in the filled Bim/ TEBs, as re-
ported above (see Figure 4E). Our findings suggest that
caspase-independent death programs can occur in the
Bim/mammary glands and can clear the ductal luminal
space with a delay of several weeks.
Detachment from the matrix, growth factor withdrawal,
andother events that compromise cellularmetabolic activ-
ity can lead to elevated levels of reactive oxygen species
(ROS), which can contribute to necrotic cell death, inde-
pendent of apoptosis (Li et al., 1999). We therefore moni-
tored ROS production to evaluate whether the nonapop-
totic ductal cells in Bim/ glands are subjected to
oxidative stress. Lipid oxidation levels revealed by immu-
noreactivity of oxidative biomarkers, such as 4-Hydroxy-
nonenal (4-HNE), are commonly used as a readout for
ROS-induced stress (Boldogh et al., 2005). Interestingly,
significant levels of 4-HNEweredetectedby immunohisto-
chemistry in the compromised Bim/ cell clusters (Fig-
ure S2), Furthermore, S100A7 (psoriasin), a calcium-bind-
ing protein, has been shown to be induced in response to
ROS-mediated stress in mammary epithelium (Carlsson
et al., 2005). In agreement with our finding of high levels
of 4-HNE, induction of S100A7 was also observed by im-
munoblot in theBim/mammary glands when compared
to control glands (Figure S2). Thus, our data indicate that
ROS-induced stress is detected in the absence of Bim
and is likely to contribute to the CICD process identified
in the Bim/ mammary ducts.
Squamous Differentiation in the Filled Bim/
TEBs and Distal Ducts
As described above, our initial histological analysis re-
vealed the presence of swirled arrays of cells that resem-
bled squamous cell clusters inBim/ TEBs and ducts. To
better characterize these cell populations and provide
clues to their lineage derivation and the mechanism asso-
ciated with this abnormal differentiation, we first analyzed
the expression of a variety of markers in wild-type and
Bim/ TEBs. There was a 5.6-fold increase in the number
of p63pos cells in Bim/ TEBs (32% ± 1.2%, n = 3) com-
pared to wild-type TEBs (5.7% ± 1.2%, n = 4), and the
squamoid clusters were p63pos (Figure 4J; Figure S3),
suggesting a basal cell origin. However, the absence of
b1-integrin (b1-INT) (Figure 5B) and a smoothmuscle actin
(aSMA) as well as the expression of keratin 6 (K6)ental Cell 12, 221–234, February 2007 ª2007 Elsevier Inc. 225
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BIM-Mediated Apoptosis in Mammary Terminal End BudFigure 3. Histology of Bim/ and Control Mammary Glands from 5 to 8 Weeks
(A and B) Sections of a (A) wild-type hollowed TEB and a (B) filled Bim/ TEB at 5 weeks. The inset in (B) shows a high-magnification view of a squa-
mous cell cluster. The scale bars are 10 mm in the main panels and 3.5 mm in the inset in (B).
(C–F) Sections of a (C) wild-type hollowed control mammary duct and a (D–F) filled Bim/ duct at 5 weeks. (E) High-magnification view of the filled
lumen shown in (D). (F) High-magnification view of a scattered keratin pearl (black arrow) in aBim/ filled duct. The scale bars are 50 mm in (C) and (D)
and 6 mm in (E) and (F).
(G) Section of a wild-type hollowed mammary duct at 6–7 weeks. The scale bar is 20 mm. Right panel: high-magnification view of (G). The scale bar is
6 mm.
(H) Section of a Bim/ filled distal mammary duct at 6–7 weeks. Note the cells filling the luminal space (black arrows). The scale bar is 20 mm. Right
panel: high-magnification view of (H). The scale bar is 6 mm.
(I) Section of a Bim/ proximal mammary duct at 6 weeks. Note the squamous cell cluster embedded in secretion (black arrow). The scale bar is
20 mm. Right panel: high-magnification view of (I). The scale bar is 6 mm.226 Developmental Cell 12, 221–234, February 2007 ª2007 Elsevier Inc.
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BIM-Mediated Apoptosis in Mammary Terminal End Bud(Figure S3) distinguished the p63pos squamous clusters
from the p63pos aSMApos b1-INTpos K6neg scattered basal
cells observed in wild-type TEBs (see Figure 5K and Fig-
ure S3 for more details). The squamous clusters were
also distinguished from basal body cells present in
Bim/ TEBs by their higher levels of cytoplasmic b-cate-
nin and basal keratins such as keratin 14 (K14) (Figure 5D)
and keratin 5 (K5) (data not shown). Interestingly, neither
the p63-positive squamoid nor the basal body cells incor-
porated BrdU, indicating a lack of proliferation in these cell
populations (Figure 5F; Figure S3).
In the skin, squamous differentiation is also associated
with loss of b1-INT as well as contact with ECM proteins.
Staining of filled Bim/ TEBs with antiserum to Laminin
(LN) demonstrated that cap cells as well as p63pos b1-
INTpos basal body cells in wild-type (Figure 5G) and
Bim/ TEBs (Figures 5H–5J) expressed LN. However,
a careful analysis by confocal microscopy showed that
the basal body cells do not deposit LN (Figures 5G and
5I), whereas cap cells did (Figure 5J). A similar expression
pattern was observed for collagen IV, another ECM pro-
tein (Figure S5). Furthermore, neither fibronectin nor fibril-
lar collagen expression was detected within wild-type or
Bim/ TEBs (see Figure S5). Our data suggest that the
cells in the filled TEBs are deprived of ECM attachment.
The Bim/ ducts contained similar cell populations to
the TEBs within the filled lumen. Inside of an outermost
K8pos MUC1pos polarized luminal population was a
p63pos b1-INTpos inner basal cell population and a p63pos
b1-INTneg population of squamous cells (see Figure 6M).
The nonsquamous basal p63pos MUC1neg b1-INTpos
K5pos subpopulation was different from the p63pos
aSMApos LNpos b1-INTpos TEB basal cells. The inner basal
cells in the ducts were not scattered, but localized in the
most inner cell layer of the epithelial islets (Figures 6B
and 6C), and did not express aSMA (Figure S4) or LN (Fig-
ures 6K and 6L). In the duct, the b1-INTneg squamous clus-
ters (Figures 6E and 6F) were distinguished by their orga-
nization into keratin pearls (foci with central keratinization
surrounding concentric layers of abnormal squamous
epithelial cell, see also Figure 3F and Figure S4) and the
expression of keratin 10 (K10) (a specific marker of the
granular skin layer) (see Figures 6H and 6I). We did not
detect expression of hair cortex cytokeratin, keratin 15,
or CD34 (follicular lineage markers), suggesting that the
Bim/ mammary cells were undergoing an interfollicular
squamous differentiation program (data not shown). The
expression of p63 was concomitantly lost in the innermost
cells of the ductal keratin pearls (Figure S4). However, we
failed to detect expression of markers of terminal skin
differentiation such as filaggrin, involucrin, and loricrin
(specific for the cornified skin layer) (data not shown).
Again, neither LN (Figures 6K and 6L), collagen IV, nor
fibronectin was detectable in the inner cell populationDevelopme(Figure S5). Thus, the loss of Bim triggered the develop-
ment of interfollicular squamous cells that underwent a
partial cornification process in the ducts.
Squamous Transdifferentiation of Mammary Cells
In Vitro upon Anoikis
Squamous differentiation in the Bim/ mammary glands
was an unexpected finding (see Figures 5 and 6 and Fig-
ures S3 and S4). We propose that MECs, similar to their
epidermal counterparts the keratinocytes, may undergo
squamous differentiation when deprived of matrix attach-
ment (Candi et al., 2005). We tested this hypothesis by
analyzing the expression of squamous markers in two
nontransformed MEC lines after detachment from the
ECM in vitro. Interestingly, both MCF-10A and HMEChTert
cells underwent squamous differentiationwithin 24 hr after
loss of ECM attachment (Figure 7A). Under these condi-
tions, the levels of skin differentiation markers such as
K10 (specific to the granular skin layer) and fillagrin (FIL,
specific for the cornified skin layer) were upregulated in
these cell lines. Immunofluorescent staining of cytospin
preparations of MCF-10A cells suspended for 24 and
48 hr confirmed the upregulation of K10 (Figure 7C and
data not shown, quantified in Figure 7D) and FIL (Figure 7F
and data not shown). In good agreement with our in vivo
findings, MCF-10A cells did not express hair cortex kera-
tin, keratin 15, or CD34 upon suspension (data not shown).
Previous reports showed that constitutive activation of the
b-catenin pathway triggered squamous transdifferentia-
tion of mammary epithelium (Miyoshi et al., 2002; Teuliere
et al., 2005). In order to test a potential involvement of the
b-catenin pathway in squamous transdifferentiation dur-
ing anoikis of MCF-10A cells, we monitored b-catenin/
TCF pathway activity in suspended MCF-10A cells. No
significant difference in TCF activity (as assayed by
TOPflash/FOPflash luciferase reporter ratio) was ob-
served after 24 hr (1.3 ± 0.3, n = 4) and 40 hr (2.4 ± 0.9,
n = 4) in suspension compared to attached MCF-10A
control cells (1.7 ± 0.6, n = 8). On the other hand, p38
mitogen-activated protein kinase (MAPK) activation was
reported to promote interfollicular keratinocyte differ-
entiation (Eckert et al., 2002). Unlike b-catenin/TCF path-
way activity, p38 MAPK activity was upregulated in
MCF-10A cells upon anoikis (see Figure 7G). Pharmaceu-
tical inhibition of p38 MAPK activation with SB203580
(Figure 7H) or SB202190 (data not shown) in MCF-10A
cells prevented keratin 10 (Figure 7H) and keratin 1 (K1)
(data not shown) upregulation in suspension. Taken to-
gether, these results suggest that squamous differentia-
tion of mammary cells upon anoikis, which occurred in
the absence of a detectable increase in b-catenin activity,
was p38 MAPK dependent.
We also tested whether MEC lines undergo squamous
differentiation upon formation of spherical acini when(J) Section of control mammary duct at 8 weeks. Note the presence of secretion in the luminal space. The scale bar is 6 mm.
(K) Section of a hollowed Bim/ proximal mammary duct at 8 weeks with debris embedded in secretion (black arrow). The scale bar is 6 mm.
(L) Section of a hollowed Bim/ distal mammary duct at 8 weeks with ghost cells (white arrow) and debris (black arrow). The scale bar is 6 mm.
cc, cap cell; bd, body cell; sq, squamous; kp, keratin pearl.ntal Cell 12, 221–234, February 2007 ª2007 Elsevier Inc. 227
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BIM-Mediated Apoptosis in Mammary Terminal End BudFigure 4. Cell Death, Proliferation, and Cell Differentiation at 5 Weeks and Caspase-Independent Cell Death at 6 Weeks in Bim/
Mammary Glands
(A andB) TUNEL staining of representative (A) wild-type TEBs and (B)Bim/ TEBs at 5weeks. (B) Residual TUNEL staining (black arrows) is observed
in Bim/ TEBs at 5 weeks. The scale bars are 6 mm.
(C and D) Immunostaining of cleaved (i.e., activated) caspase 3 (red) and b-catenin (green) in a representative (C) wild-type TEB and (D)Bim/ TEB at
5 weeks. (D) Small numbers of cleaved caspase 3-positive cells (white arrows) are observed in Bim/ TEBs at 5 weeks. The scale bars are 6 mm.
(E) Quantification of TUNEL and cleaved caspase 3-positive cells expressed as mean ± SD in TEBs of 5-week-old mice (n = 5 per genotype).
Percentages of TUNEL-positive cells were 10.6% ± 1.7% in wild-type and 1.1% ± 0.45% in Bim/ TEBs. Percentage of cleaved caspase 3-positive
cells were 10.7% ± 1.75% in wild-type and 1.86% ± 0.38% in Bim/ TEBs.
(F and G) BrdU staining (black arrow) of representative (F) wild-type TEBs and (G) Bim/ TEBs at 5 weeks. The scale bars are 6 mm.
(H) Proliferation assay in TEBs from 5-week-old mice (n = 5 per genotype). The percentages (mean ± SD) of BrdU-positive cells were 28% ± 3.1% in
wild-type and 19.7% ± 4.2% in Bim/ TEBs (paired t test with p < 0.02).
(I and J) MUC1 (green) and p63 (red) expression in (I) wild-type and (J) Bim/ TEBs. The inset in (I) shows a high-magnification view of the MUC1 and
p63 overlay from the dashed box. The upper inset in (J) shows a high-magnification view of theMUC1 and p63 overlay from the dashed box. The lower
inset in (J) shows MUC1 staining alone. Note that the p63-positive cells were MUC1 negative in Bim/ TEBs (white asterisks). The scale bars in the
main panels are 8 mm; the scale bar in the inset in (J) is 4 mm.
(K and L) Colocalization, shown by immunostaining, of b-CAT- (green) and TUNEL-positive (red) cells (white arrows) in a Bim/ clearing duct at
6 weeks. (L) High-magnification view of the cell cluster shown in (K). Lower inset: corresponding DAPI staining (white asterisks). The scale bar in
(K) is 4 mm, and the scale bar in (L) is 2.5 mm.228 Developmental Cell 12, 221–234, February 2007 ª2007 Elsevier Inc.
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BIM-Mediated Apoptosis in Mammary Terminal End BudFigure 5. Characterization of the Inner Cell Population of the Filled Bim/ TEBs at 5 Weeks
(A and B) Colocalization by immunostaining of b1-INT (green) and b-CAT (red) in a (A) wild-type and a (B) Bim/ TEB at 5 weeks. (B) Note that the
highly positive b-CAT clusters are b1-INT negative (white arrows and asterisks). The inset shows a high-magnification view of the b1-INT-negative
clusters in the dashed box. The scale bars in the main panels are 15 mm; the scale bar in the inset in (D) is 8 mm.
(C and D) Immunostaining of b1-INT (green) and K14 (red) in a (C) wild-type and a (D) Bim/ TEB at 5 weeks. Nuclei are in blue. (D) The b1-INT-neg-
ative cell clusters in TEBs express high levels of K14 (white arrow). The inset shows that b1-INTpos basal cells express K14 as well (dashed box in [D]).
The scale bars in the main panels are 15 mm; the scale bar in the inset of (D) is 8 mm.
(E and F) BrdU incorporation (green) and p63 expression (red) in (E) wild-type and (F) Bim/ TEBs. Right panel in (F): p63 and BrdU overlay of the
dashed boxes shown in (F). Note that the p63pos cells in the TEB body did not incorporate BrdU. The scale bars in the main panels are 15 mm; the
scale bar in the inset in (F) is 8 mm.
(G–I) Immunostaining of b1-INT (green) and LN (red) in a (G) wild-type TEB and a (H) Bim/ TEB at 5 weeks. (G) The inset shows cytoplasmic local-
ization of LN in TEB basal cells (white arrows in [G]). (H) The b1-INT-negative cell clusters do not express LN (white asterisk). (I) Confocal imaging of
basal cells in TEBs (see the white arrow in [H]) showing a cytoplasmic localization of LN. The scale bar in (H) is 15 mm, the scale bar in the inset in (G) is
3 mm, and the scale bar in (I) is 3 mm.
(J) Confocal imaging of cap cells showing extracellular localization of LN. The scale bar is 3 mm.
(K) Diagram summarizing the expression of differentiation markers in the cell populations present in a filled TEB at 5 weeks. Expressed proteins are in
red, and those not expressed are in green.
b1-INT, b1-integrin; b-Cat, b-catenin; LN, Laminin; K14, keratin 14; cc, cap cells; BrdU, Bromodeoxyuridine.cultured in reconstituted basement membrane. We hy-
pothesized that the inner cell populations in 3D acini, like
the inner cells in the Bim/ ducts, might show squamousDevelopmedifferentiation upon loss of matrix attachment. Although
a squamous population of inner cells was not a common
feature of MCF-10A acini (data not shown), we found(M–O) Immunostaining of b-CAT (green) and cleaved caspase 3 (red) in a filledBim/ duct at 6 weeks. (N) High-magnification view of the area labeled
with a white asterisk in (M). Note that luminal epithelial cells are organized into large, isolated ductal islets (white arrow). (O) High-magnification view of
the dashed box in (M). Upper and lower insets show corresponding DAPI staining of the dashed boxes in (O). The scale bars are 12 mm in (M), 6 mm in
(N), and 5 mm in (O).
(P) Immunostaining of b-CAT- (green) and TUNEL-positive (red) cells in a keratin pearl with TUNEL-positive cells (white arrows). Right panel: DAPI
staining of the main panel. The scale bar is 4 mm.
(Q) Immunostaining of b-CAT (green) and cleaved caspase 3 (red) in a compromised squamous cluster in aBim/ duct at 6 weeks. Note the absence
of b-CAT staining and the thin shape of nuclei in the peripheral cells (white arrows). The scale bar is 4 mm.
(R) Quantification (mean ± SD) of TUNEL-positive (10.6% ± 0.8%, n = 3) and cleaved caspase 3-positive (0.75% ± 0.15%, n = 4) cells in the ducts of
6-week-old Bim/ mice. Nuclei are in blue.
b-Cat, b-catenin; Casp3*, cleaved caspase 3; MUC1, Mucin-1.ntal Cell 12, 221–234, February 2007 ª2007 Elsevier Inc. 229
Developmental Cell
BIM-Mediated Apoptosis in Mammary Terminal End BudFigure 6. Characterization of the Inner Cell Population of the Filled Bim/ Ducts at 5 Weeks
(A–C) Colocalization by immunostaining of p63 (green) and MUC-1 (red) in (A) wild-type and (B and C) Bim/ ducts. (A) Note the apical localization of
MUC-1 in luminal cells of the control duct; p63 expression is restricted to the myoepithelial cells. (B and C) Note that in the Bim/ filled duct inner
MUC1neg cells express p63 (white arrow). The lower panel in (C) shows confocal imaging of the dashed box shown in the upper panel. Note the apical
localization of MUC1 in the luminal/inner cells (double-headed white arrows). The scale bars in (A) and (B) and in the upper panel of (C) are 7 mm; the
scale bar in the lower panel of (C) is 4 mm.
(D–F) Immunostaining of b1-INT (green) and b-CAT (red) in a (D) wild-type hollowed duct and a (E and F) Bim/ filled TEB. The top inset in (E) shows
a b1-INTneg squamous cluster (white arrow). The lower inset in (E) shows a high-magnification view of the dashed box. (F) Corresponding b1-INT stain-
ing of the right inset in (E). Note that the squamous clusters are b1-INT negative (white asterisks). The scale bars in (D) and (E) are 15 mm; the scale bars
in the inset in (E) and in (F) are 10 mm.
(G and H) Indirect immunofluorescence for K10 (green) and K8 (red) in (G) Bim+/+ and (H) Bim/ mammary ducts. (H) Note that only a subset of the
K8-negative cells (white asterisks) are K10 positive. The right inset shows a high-magnification view of the left inset without DAPI staining. The scale
bars in (G) and (H) are 15 mm; the scale bar in the inset in (H) is 5.5 mm.
(I) Immunostaining of b1-INT (green) and K10 (red) of a keratin pearl in a filled distal Bim/ duct. Lower inset: note that the keratin pearl is b1-INTneg.
The scale bar in the inset in (I) is 7 mm.
(J–L) Immunostaining of b1-INT (green) and LN (red) in a (J) wild-type and (K and L) Bim/ distal ducts. The inset in (J): confocal imaging showing
extracellular localization of LN in the mammary ducts. (L) Confocal imaging showing extracellular localization of LN at the level of the myoepithelial
cells in the filled mammary ducts. The scale bars in (J) and (K) are 15 mm; the scale bar in (L) is 3mm.
(M) Diagram summarizing the expression of differentiation markers in the cell populations present in a filled Bim/ distal duct at 5 weeks. Expressed
proteins are in red, and those not expressed are in green.
myo, myoepithelial cells; lum, luminal cell; b1-INT, b1-integrin; b-Cat, b-catenin; LN, Laminin; MUC1, Mucin-1; K8, keratin 8; K10, keratin 10.that HMEChTert cells underwent dramatic squamous
differentiation in 3D culture (Figure 7I). The HMEChTert
acini contained centrally localized squamous pearls that
lacked b1-INT and displayed stratified cells expressing
K10 and K1 (also specific to the granular skin layer) in
the outermost layers and loricrin (a marker for terminal
skin differentiation) in the innermost layer (Figures 7J230 Developmental Cell 12, 221–234, February 2007 ª2007 Eland 7K). Meanwhile, the outermost cell layer, which main-
tained contact with the ECM (Figure 7L), did not show
evidence of skin differentiation, indicating that this pro-
cess was likely induced by loss of ECM attachment.
Taken together, these studies indicate thatMECs undergo
squamous differentiation when they are deprived of
matrix.sevier Inc.
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BIM Regulates Apoptosis during Mammary
Ductal Morphogenesis
The data presented here demonstrate that the BH3-only
protein BIM plays a role in mammary ontogenesis in the
mouse. BIM is required for the induction of apoptosis in
the body cells of developing TEBs. The failure of Bim/
TEB body cells to undergo apoptosis prevents lumen for-
mation in TEBs and causes a delay in the clearing of adja-
cent ducts. Cells that fail to undergo apoptosis in ducts do
eventually die by CICD.
Previously, Humphreys et al. (1996) showed that mam-
mary TEBs displayed a striking pattern of apoptosis, re-
stricted to an area near the presumptive luminal spaces.
As shown by TUNEL staining, 11% of the cells in TEBs
appeared to undergo this death process at any given
time. This led to the proposal that programmed cell death
(PCD) in highly proliferative TEBs maintains the lumen
within the expanding duct. Moreover, this PCD process
was previously shown to be independent of p53 and to
be partially suppressed when the prosurvival protein
BCL-2 was overexpressed (Humphreys et al., 1996). Nei-
ther the molecular mechanisms underlying the program
that regulates death upstream of caspase activation nor
the consequences of inhibition of apoptosis had been de-
fined. Here, we show that the loss of Bim triggers an10-
fold decrease in apoptotic cell death in TEBs (to 1.1%).
Humphreys and colleagues described only an 1.5-fold
decrease (to 6.3%) due to the overexpression of Bcl-2 un-
der the control of the WAP promoter. In contrast to the
phenotype reported for WAP:Bcl-2 mice, we did not de-
tect any dramatic apoptotic activity in the neck of the filled
Bim/ TEBs, but rather a luminal filling in the distal ducts.
Interestingly, hyperactivation of the Hedgehog signaling
pathway in Patched+/ mice has also been reported to
produce a transient distal luminal filling; however, this ef-
fect is independent of any perturbation of cell apoptosis
or proliferation rate (Lewis et al., 1999).
Remarkably, the process of lumen formation in MCF-
10A 3D basement membrane cultures shares many fea-
tures with clearance of excess cells in TEBs and ducts
during pubertal expansion. For instance, both processes
involve BIM-dependent apoptosis. Inhibition of apoptosis
delays, but does not prevent, the formation of a hollow
lumen in both models (Debnath et al., 2002; Reginato
et al., 2005). Thus, our in vivo data provide evidence for
the relevance of 3D in vitro models for analysis of certain
aspects of mammary morphogenesis.
Caspase-Independent Cell Death
in Epithelial Morphogenesis
Our data suggest that CICD can compensate for the loss
of BIM-dependent apoptosis in the formation of a luminal
space in mammary gland ducts during puberty. By defini-
tion, CICD occurs when there is a failure of apoptotic
stimuli to activate caspases (Chipuk and Green, 2005).
Usually, this process is revealed in vitro after treatment
with caspase inhibitors and in vivo when the pathway isDevelopmgenetically disrupted. In Bim/ filled ducts at 6 weeks,
the number of apoptotic cells is extremely low, yet TUNEL
staining revealed the presence of DNA fragmentation
within epithelial islets and squamous pearls, highlighting
a CICD program. Even though the TUNEL assay is rou-
tinely used for examining apoptosis/PCD, this technique
labels the 30-OH termini of DNA breaks that are generated
during both apoptosis and necrosis (Chipuk and Green,
2005). Indeed, these TUNEL-positive cells in the Bim/
ducts displayed necrotic features such as compromised
cytoarchitecture and karyolysis, as well as evidence of
oxidative stress (lipid oxidation and psoriasin expression),
and they lacked apoptotic features such as cellular bleb-
bing and nuclear condensation. CICD has been observed
in several mouse models, such as Caspase 3/, Caspase
9/, or Apaf-1/ in which apoptotic mediators are de-
leted by homologous recombination (Chipuk and Green,
2005). Caspase activation and apoptosis are ultimately
not required for lumen formation of the mammary gland
in vivo. Our study strongly suggests that CICD is an effi-
cient backupmechanism tocompensate for compromised
apoptotic core machinery during epithelial ontogenesis.
Potential Contribution of Other BH3-Only
Proteins in Apoptotic Cell Death during
Mammary Gland Development
Although our data implicate a CICD process in the clearing
of Bim/ ducts, apoptotic cell death was not completely
inhibited. We observed a small number of cells undergo-
ing apoptotic PCD (0.75%) in Bim/ TEBs and ducts,
suggesting that other proapoptotic factors may act in par-
allel to BIM and/or compensate for Bim loss, albeit to a
minor extent. We therefore cannot exclude the possibility
that residual caspase-associated apoptosis participated
in a minor way to the clearance process observed in the
Bim/ ducts. It remains to be determined which other
BH3-only proteins, if any at all, could be responsible for
the residual apoptosis in theBim/mice.With the excep-
tion of BIM (this study), BAD is the only BH3-only protein
whose expression has been thoroughly investigated in
the mammary gland; however, BAD expression was not
detectable during virgin development and was upregu-
lated only during lactation (Metcalfe et al., 1999). Regard-
less, any other putative proapoptotic factors that could
have compensated for BIM loss in apoptotic cell death
during mammary ductal morphogenesis may do so very
poorly, as CICD appeared to be the main contributor to
luminal clearing in the absence of Bim.
Squamous Transdifferentiation
of Mammary Epithelial Cells
Squamous differentiation in the Bim/ mammary glands
was an unexpected finding. During skin differentiation,
the lack of ECM attachment in keratinocytes leaving the
basal layer, concomitantly with the loss of b1-INT expres-
sion, is known to initiate their differentiation (Candi et al.,
2005). Here, to our knowledge, we show for the first time
that lack of ECM attachment may trigger a similar process
in mammary cells.ental Cell 12, 221–234, February 2007 ª2007 Elsevier Inc. 231
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BIM-Mediated Apoptosis in Mammary Terminal End BudFigure 7. Squamous Transdifferentiation of Mammary Epithelial Cell Lines In Vitro
(A) Immunoblot showing K10 and FLG expression in attached cells and induction upon suspension at 24 hr and 72 hr inMCF-10A andHMEChTert cells.
Note induction of BIM (Stressgen antibody AAP-330) in MCF-10A cells upon anoikis as described previously (Reginato et al., 2003). TUB was used as
loading control.
(B and C) K10 (green) and b1-INT (red) immunofluorescence on cytospin samples of (B) attached cells and (C) cells in suspension for 24 hr. The scale
bars are 15 mm.
(D) Quantification (mean ± SD) of keratin 10-positive MCF-10A cells for the attached (7.24% ± 1.99%) condition and after 24 hr (33.8% ± 3.46%)
or 48 hr (55% ± 2%, p < 0.001) in suspension.
(E and F) FLG immunofluorescence on cytospin samples of (E) attached cells and (F) cells in suspension for 24 hr. The scale bars are 15 mm.
(G) Upregulation of p38 MAPK pathway activity upon anoikis. Immunoblot showing upregulation of phosphorylation of p38 MAPK and its upstream
MAPKs, MKK3 andMKK6, upon suspension at 24 hr and 48 hr inMCF-10A cells. Note that the total levels ofMKK3 andMKK6 increased upon anoikis,
while the level of p38 MAPK protein did not change. TUB was used as a loading control.
(H) Pharmacological inhibition of p38 MAPK activation suppressed K10 expression. SB203580 treatment (10 mM in DMSO) decreased phosphory-
lation of p38 MAPK and prevented K10 upregulation in suspension at 24 hr, while treatment with the carrier alone (DMSO) did not inhibit upregulation
of p38MAPKphosphorylation andK10 protein expression. Note that the total level of p38MAPKprotein does not change upon anoikis. TUBwas used
as a loading control.
(I) Microphotography of HMEChTert acini after 20 days of culture. Note the ‘‘onion skin’’ shape of the inner cells (black arrow in the low-magnification
panel). Lower panel: high-magnification view of the upper panel. Note the lumen (black asterisk). The scale bar in the main panel is 430 mm, and the
scale bar in the inset is 180 mm.
(J) Immunostaining for K10 (green) and LOR (red) in HMEChTert acini with a hollow lumen (white asterisk) at day 20. The dashed, white line displays
HMEChTert acinus borders. Inset: LOR staining alone with DAPI of the dashed box shown in the main panel. The scale bar is 35 mm.
(K) Immunolocalization of K1 in HMEChTert acini at day 20. The scale bar is 50 mm.232 Developmental Cell 12, 221–234, February 2007 ª2007 Elsevier Inc.
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population are luminal cells and only a few scattered basal
cells; however, the basal body cell population was ampli-
fied in Bim/ TEBs. We speculate that the squamous
cells are derived from this amplified but quiescent basal
cell population deprived of ECM attachment because
the squamous cells are positive for p63 and K5 and nega-
tive for the luminal markers K8 and MUC1. However, un-
like basal body cells, the squamous cells are negative
for b1-INT, LN, and aSMA, and they are positive for K10,
a specific marker of the granular skin layer. The loss of
b1-INT and LN expression in the mammary body cells
correlated with squamous transdifferentiation; the same
changes in gene expression accompany basal cell differ-
entiation into squamous cells in the skin (Candi et al.,
2005). The failure to detect markers of the cornified layer
suggests that the skin differentiation program might not
be carried out to completion. Also, CICD could eliminate
these quiescent cells before their complete differentiation
and thus prevent detection of these stratification markers.
Our in vivo observations in the Bim/ mammary gland
are reinforced by our in vitro study of nontransformed
mammary cells, which display features of squamous
differentiation upon detachment from matrix. Microarray
analysis of MCF-10A cells in suspension (i.e., undergoing
anoikis) has also revealed the existence of a transcriptional
epidermis development program (T.S. and J.S.B., unpub-
lished data). Furthermore, the keratin pearls formed by the
HMEChTert cells in 3D culture on the reconstituted base-
ment membrane mimic the skin differentiation process.
These data show that mammary cells can undergo com-
plete stratification associated with keratinization; the
outermost layers express markers of the granular layer,
and the innermost cells express proteins specific to the
cornified layer.
It has been reported that squamous differentiation in the
mammary gland can be induced by activation of the b-
catenin pathway. In previous studies, the overexpression
of stabilized b-catenin in mammary luminal cells (Miyoshi
et al., 2002) and myoepithelial cells (Teuliere et al., 2005)
resulted in the development of squamous metaplasia ex-
pressing follicular epithelial lineage markers. In the pres-
ent study, we discovered that lack of ECM attachment
and subsequent activation of the p38 MAPK signaling
pathway triggered squamous differentiation of mammary
cells, apparently independent of b-catenin activation. In
addition, this alternate mechanism promoted an interfol-
licular differentiation program, revealed by the absence
of expression of follicular markers.
The concept of epidermal transdifferentiation of mam-
mary cells is also supported by the fact that skin and
mammary glands share the same embryonic origin in the
ectoderm. Therefore, we propose that squamous differen-
tiation could be an intrinsic property of mammary cells.DevelopmFinally, cornification is considered to function as a cell
death process (Candi et al., 2005) and may act in parallel
to CICD and PCD to eliminate mammary cells in an anoi-
kis-like process within the luminal space. These data raise
interesting questions about CICD and squamous differen-
tiation as tumor-suppressive mechanisms in mammary
cells during anoikis, as repopulation of the luminal space
with cancer cells is a hallmark of early breast tumors.
EXPERIMENTAL PROCEDURES
Mouse Strains
All experiments with mice were performed according to the guidelines
of the IACUCcommittee ofHarvardMedical School.Bim/ andBim+/
mice and embryos were generated as previously described (Bouillet
et al., 2001) and were in the C57BL/6 background. C57BL/6 wild-
type littermates were used as control at different stages of mammary
development. The number of Bim/ female mice used in this study
at the different stages were as follows: 1 week, n = 3; 4 weeks, n = 3;
5 weeks, n = 9; 6 weeks, n = 9; 8 weeks, n = 6.
Whole-Mount Mammary Gland Staining and Histology
For whole-mount staining, either the third or fourth pair of mammary
glands was spread on microscope slides and stained with carmine
alum overnight as described previously (Teuliere et al., 2005). LacZ ex-
pression on whole-mount mammary glands and embryos was moni-
tored by detecting b-galactosidase activity as described previously
(White et al., 2004).
For histological analysis, mammary gland specimens were fixed in
methacarn or 4% paraformaldehyde in PBS and dehydrated. Samples
were embedded in paraffin, then cut (5 mm sections) at the Rodent
Histopathology Service Facility (Harvard Medical School, Boston)
and stained with hematoxylin (Vector Lab) and eosin (Sigma-Aldrich).
All digital images of light and fluorescence microscopy were acquired
with a TE 300 fluorescence microscope (Nikon).
BrdU Incorporation and TUNEL Assays
To assess cell proliferation, wild-type (n = 4) and mutant (n = 5) mice
were injected intraperitoneally with 0.25 mg 5-bromo-20-deoxyuridine
(BrdU) per gram of body weight 2 hr prior to sacrifice. BrdU incorpora-
tion was detected on sections by immunohistochemistry, followed by
a light counterstaining with hematoxylin. A total of 1000–1500 nuclei
per sample were counted. To detect apoptotic nuclei, paraffin-embed-
ded sections from wild-type (n = 5) and mutant mice (n = 6) were ana-
lyzed by TdT digoxygenin nick-end labeling with the Apoptag Plus kit
(Chemicon) by following the manufacturer’s instructions.
Cell Culture and cDNA Constructs
MCF-10A MECs were obtained from the American Type Culture
Collection (Manassas, VA) and cultured according to ATCC instruc-
tions. HMEC cells were purchased from Cambrex (East Rutherford,
NJ) and were cultured according to manufacturer’s protocol. The
HMEChTert cell line was generated with retrovirus produced from the
pBabe-hygro:hTert vector as described previously (Overholtzer
et al., 2006). For morphogenesis assays, HMEChTert cells were resus-
pended in MEGM medium (Cambrex). Eight-well RS glass slides (BD
Falcon) were coated with 50 ml Growth Factor-reduced Matrigel (BD
Biosciences) per well. A total of 5000 cells were plated per well in
MEGM medium containing a final concentration of 2% Matrigel.
MEGM medium containing 2% Matrigel was replaced every 4 days
(Debnath et al., 2003).(L) Colocalization of b1-INT (green) and b-CAT (red) by immunostaining in HMEChTert acini at day 20. Note the absence of b1-INT expression in the
squamous inner cells (double head arrow) and the faint DAPI staining in the center of the acinus (white arrows). The scale bar is 30 mm.
att. and Attach., attached; ano., anoikis; sus., suspension; sq., squamous; b1-INT, b1-integrin; b-Cat, b-catenin; FLG, Filaggrin; LOR, Lloricrin; K1,
keratin 1; K10, keratin 10; P-MMK3/6, phospho-MKK3/6; P-p38, Phospho-p38 MAPK; TUB, tubulin.ental Cell 12, 221–234, February 2007 ª2007 Elsevier Inc. 233
Developmental Cell
BIM-Mediated Apoptosis in Mammary Terminal End BudSupplemental Data
Supplemental Data include information on immunoblot assay, anoikis,
cytospin preparation, immunohistochemistry, and antibodies and are
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